首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Evaluation of hydrate formation of a pharmaceutical solid by using diffuse reflectance infrared Fourier-transform spectroscopy.
【24h】

Evaluation of hydrate formation of a pharmaceutical solid by using diffuse reflectance infrared Fourier-transform spectroscopy.

机译:通过使用漫反射红外傅里叶变换光谱法评估药物固体的水合物形成。

获取原文
获取原文并翻译 | 示例
           

摘要

Ampicilline and nitrofurantoin, in both anhydrous and hydrate forms, were characterized by powder X-ray diffractometry (PXRD), thermogravimetric and differential thermal analyses (TG/DTA) and diffuse reflectance FT-IR spectroscopy (DRIFTS). Of all the analytical tools applied, only DRIFTS was able to indicate the formation of hydrogen bonds between the molecules of the anhydrous drug substance and crystalline water uptaken from atmospheric moisture as evidenced by the significant absorption at 3500-3700cm(-1) corresponding to crystal water. These results suggested that DRIFTS could provide information on hydration without a standard sample and accurately evaluate the physical stability focusing on the qualification of slight hydration in the early stages of pharmaceutical development. In addition, DRIFTS was applied to the besylate salt of pharmaceutical compound A to identify any possible hydration. This salt had the stable form BSA-I, metastable form BSA-II and hydrate form BSA-III. DRIFTS was able to show the hydration of BSA-II even when stored in a capped bottle, eventually leading to the transformation into BSA-III, which was not detected by PXRD. These findings verify the usefulness of DRIFTS for the solid-state characterization of pharmaceutical substances, especially the monitoring of gradual hydration.
机译:通过粉末X射线衍射(PXRD),热重和差热分析(​​TG / DTA)以及漫反射FT-IR光谱(DRIFTS)对无水和水合物形式的氨苄青霉素和呋喃妥因进行了表征。在所有应用的分析工具中,只有DRIFTS能够表明无水药物分子与从大气水分中吸收的结晶水之间形成氢键,这一点由对应于晶体的3500-3700cm(-1)处的明显吸收所证明。水。这些结果表明,DRIFTS可以在没有标准样品的情况下提供有关水合作用的信息,并可以在药物开发的早期阶段以轻度水合的合格性为重点准确评估物理稳定性。另外,将DRIFTS应用于药物化合物A的苯磺酸盐以鉴定任何可能的水合。该盐具有稳定的BSA-I形式,亚稳的BSA-II形式和水合物的BSA-III形式。即使将其储存在加盖的瓶子中,DRIFTS仍能显示BSA-II的水合状态,最终导致转化为BSA-III,而PXRD并未检测到。这些发现证实了DRIFTS对于药物物质的固态表征,特别是对逐步水合的监测的有用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号